Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Roberto Gnavi, Moreno Demaria, Roberta Picariello, Marco Dalmasso, Fulvio Ricceri, Giuseppe Costa
Abstract
Exposure to agents acting on the renin-angiotensin system was not associated with a risk increase of COVID-19 infection in 2 Italian matched case-control studies, 1 nested in hypertensive patients and the other in patients with cardiovascular diseases or diabetes.
Topics & Concepts
MedicineRenin–angiotensin systemRespiratory systemBetacoronavirusCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe acute respiratory syndromeRespiratory diseaseIntensive care medicineImmunologyInternal medicineLungDiseaseInfectious disease (medical specialty)Blood pressureCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19